The US market for in vitro diagnostic (IVD) products will grow 5.1 percent annually to $20 billion in 2011.
April 26, 2007 (Press Release) --
In Vitro Diagnostics industry forecasts to 2011 & 2016
Clinical chemistry,immunoassays to remain dominant product groups
The US market for in vitro diagnostic (IVD) products will grow 5.1 percent annually to $20 billion in 2011. Based on extensive use in pre-hospital admission screening, basic physical examinations and diabetes self-monitoring, clinical chemistry will remain the top-selling product group through 2011 and beyond. However, clinical chemistry diagnostics will generate below-average growth in demand. While sales of blood glucose test strips will increase at a strong pace as the number of diabetic patients expands, the market for clinical chemistry reagents and instruments employed in basic patient screening will grow slowly due to consolidation in the clinical laboratory market and decreasing consumable requirements per test.
Established uses in metabolic and infectious disease detection and therapeutic drug monitoring, coupled with increasing applications in cancer, cardiovascular disease and congenital marker testing, will keep immunoassays the second-largest selling IVD product group. However, overall growth opportunities for immunoassay diagnostics will decelerate over the next decade due to increasing competition from nucleic acid and cellular analysis testing products. Competitive and market trends will also weaken growth prospects for IVD products used in blood testing applications. Advances in immunoassays, PCR and microarray technologies will moderate gains in demand for hematology reagents and instruments. Trends toward less invasive surgery will soften growth prospects for blood banking diagnostics. Improvements in the safety of anticoagulant and thrombolytic therapies will slow gains in sales of hemostasis testing products.
For more information, Please visit : http://www.bharatbook.com/detail.asp?id=8047
or email us at : info@bharatbook.com
You can also call us at +91-(022)-2757 8668 or +91-(022)-2757 9131
For searching our huge collection of reports, Please visit :
http://www.bharatbook.com/general/customresearch.asp
Clinical chemistry,immunoassays to remain dominant product groups
The US market for in vitro diagnostic (IVD) products will grow 5.1 percent annually to $20 billion in 2011. Based on extensive use in pre-hospital admission screening, basic physical examinations and diabetes self-monitoring, clinical chemistry will remain the top-selling product group through 2011 and beyond. However, clinical chemistry diagnostics will generate below-average growth in demand. While sales of blood glucose test strips will increase at a strong pace as the number of diabetic patients expands, the market for clinical chemistry reagents and instruments employed in basic patient screening will grow slowly due to consolidation in the clinical laboratory market and decreasing consumable requirements per test.
Established uses in metabolic and infectious disease detection and therapeutic drug monitoring, coupled with increasing applications in cancer, cardiovascular disease and congenital marker testing, will keep immunoassays the second-largest selling IVD product group. However, overall growth opportunities for immunoassay diagnostics will decelerate over the next decade due to increasing competition from nucleic acid and cellular analysis testing products. Competitive and market trends will also weaken growth prospects for IVD products used in blood testing applications. Advances in immunoassays, PCR and microarray technologies will moderate gains in demand for hematology reagents and instruments. Trends toward less invasive surgery will soften growth prospects for blood banking diagnostics. Improvements in the safety of anticoagulant and thrombolytic therapies will slow gains in sales of hemostasis testing products.
For more information, Please visit : http://www.bharatbook.com/detail.asp?id=8047
or email us at : info@bharatbook.com
You can also call us at +91-(022)-2757 8668 or +91-(022)-2757 9131
For searching our huge collection of reports, Please visit :
http://www.bharatbook.com/general/customresearch.asp
Email
Print
SPAM
LEAVE A COMMENT
